Reinout Hesselink

Reinout is a seasoned professional in cell and gene therapies manufacturing, with over 17 years of experience in CMC, regulatory, and quality assurance. He has developed cell and gene therapy production processes from early clinical development to commercial products and has helped write and file IMPDs, INDs, and market applications. Reinout has previously held management positions at BioNTech, PhamaCell, and CiMaas.